PCN119 COST EFFECTIVENESS ANALYSIS OF ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT THERAPY FOR EARLY STAGE BREAST CANCER BASED ON THE 100-MONTH ANALYSIS OF THE ATAC TRIAL FROM A GERMAN PERSPECTIVE

Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603804 ◽

2007 ◽

Vol 97 (2) ◽

pp. 152-161 ◽

Cited By ~ 38

Author(s):

R Mansel ◽

◽

G Locker ◽

L Fallowfield ◽

Á Benedict ◽

...

Keyword(s):

Breast Cancer ◽

United Kingdom ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Early Stage ◽

The United Kingdom ◽

Effectiveness Analysis ◽

Treatment Analysis

Abstract P4-12-05: Cost-effectiveness analysis of second-generation multi-gene expression prognostic assays compared with the standard 21-gene recurrence score assay to guide adjuvant therapy decisions in women with early stage breast cancer

10.1158/1538-7445.sabcs17-p4-12-05 ◽

2018 ◽

Author(s):

MB Hannouf ◽

GS Zaric ◽

M Brackstone

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Second Generation ◽

Early Stage ◽

Recurrence Score ◽

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

The Pharmacogenomics Journal ◽

10.1038/s41397-019-0089-x ◽

2019 ◽

Vol 20 (1) ◽

pp. 27-46 ◽

Cited By ~ 7

Author(s):

Malek B. Hannouf ◽

Gregory S. Zaric ◽

Phillip Blanchette ◽

Christine Brezden-Masley ◽

Mike Paulden ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Expression Profiling ◽

Early Stage ◽

Effectiveness Analysis ◽

Multigene Expression

Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

PharmacoEconomics ◽

10.1007/s40273-016-0474-0 ◽

2016 ◽

Vol 35 (4) ◽

pp. 425-438 ◽

Cited By ~ 8

Author(s):

Kelly Fust ◽

Xiaoyan Li ◽

Michael Maschio ◽

Guillermo Villa ◽

Anju Parthan ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Febrile Neutropenia ◽

Hodgkin Lymphoma ◽

Early Stage ◽

Treatment Strategies ◽

Non Hodgkin Lymphoma ◽

Cost-Effectiveness Analysis of Intraoperative Radiation Therapy for Early-Stage Breast Cancer

Annals of Surgical Oncology ◽

10.1245/s10434-013-2997-3 ◽

2013 ◽

Vol 20 (9) ◽

pp. 2873-2880 ◽

Cited By ~ 41

Author(s):

Michael D. Alvarado ◽

Aron J. Mohan ◽

Laura J. Esserman ◽

Catherine C. Park ◽

Brittany L. Harrison ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Cost Effectiveness ◽

Early Stage ◽

Intraoperative Radiation Therapy ◽

Intraoperative Radiation ◽

Cost-effectiveness analysis (CEA) of adjuvant trastuzumab therapy use in HER2-positive early-stage breast cancer (EBC)

Annals of Oncology ◽

10.1093/annonc/mdw377.11 ◽

2016 ◽

Vol 27 ◽

pp. vi353

Author(s):

K.I. Quintyne ◽

B. Woulfe ◽

A. Dee ◽

R. Gupta

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Trastuzumab Therapy ◽

Response to: ‘Reply to: Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast Cancer’

Clinical Oncology ◽

10.1016/j.clon.2017.03.013 ◽

2017 ◽

Vol 29 (6) ◽

pp. 393-394

Author(s):

M. McGuffin ◽

T. Merino ◽

B. Keller ◽

J.-P. Pignol

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

External Beam ◽

Effectiveness Analysis ◽

Radiotherapy Techniques ◽

The Cost

Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast Cancer

Clinical Oncology ◽

10.1016/j.clon.2016.11.010 ◽

2017 ◽

Vol 29 (3) ◽

pp. e57-e63 ◽

Cited By ~ 11

Author(s):

M. McGuffin ◽

T. Merino ◽

B. Keller ◽

J.-P. Pignol

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

External Beam ◽

Effectiveness Analysis ◽

Radiotherapy Techniques ◽

The Cost

Partial-Breast Irradiation Versus Whole-Breast Irradiation for Early-Stage Breast Cancer: A Cost-Effectiveness Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2008.08.015 ◽

2009 ◽

Vol 74 (2) ◽

pp. 440-446 ◽

Cited By ~ 43

Author(s):

David J. Sher ◽

Eve Wittenberg ◽

W. Warren Suh ◽

Alphonse G. Taghian ◽

Rinaa S. Punglia

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

Partial Breast Irradiation ◽

Whole Breast Irradiation ◽

Breast Irradiation ◽

Reply to: Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast Cancer

Clinical Oncology ◽

10.1016/j.clon.2017.03.003 ◽

2017 ◽

Vol 29 (6) ◽

pp. 392-393 ◽

Cited By ~ 1

Author(s):

J. Michael ◽

J. Crook ◽

D. Morton ◽

D. Batchelar ◽

M. Hilts ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Stage ◽

External Beam ◽

Effectiveness Analysis ◽

Radiotherapy Techniques ◽

The Cost